参考文献/References:
[1] Jemal A,Center MM,DeSantis C,et al.Global patterns of cancerincidence and mortality rates and trends[J].Cancer Epidemiol Biomarkers Prey,2010,19(8):1893-1907.
[2] 韦志鹃,张晓云.血清胃功能检测在早期胃癌筛查中的临床应用研究[J].国际检验医学杂志,2017,38(16):2240-2242.
Wei ZJ,Zhang XY.Clinical application of serum gastric function detection in early gastric cancer screening[J].International Journal of Laboratory Medicine,2017,38(16):2240-2242.
[3] 吕艳丽,李 毅,刘光顺,等.胃癌高发区血清胃蛋白酶原初筛加高危人群胃镜检查方案与直接胃镜筛查方案的效果比较[J].中华肿瘤杂志,2013,35(5):394-397.
L(¨overu)YL,Li Y,Liu GS,et al.Comparison of two gastric cancer screening schemes in a high-risk population[J].Chinese Journal of Oncology,2013,35(5):394-397.
[4] 李月红,张祥宏,黄 飚,等.胃癌高发区居民血清胃蛋白酶原水平及异常标准的研究[J].中华流行病学杂志,2006,27(10):840-844.
Li YH,Zhang XH,Huang B,et al.Studies on the cut-off value of serum pepsinogen abnormality for screening chronic atrophic gastritis and gastriccarcinoma[J].Chin J Epidemiol,2006,27(10):840-844.
[5] 刘春兴.上海地区胃蛋白酶原参考值的建立及临床应用[J].现代检验医学杂志,2015,30(1):121-123,125.
Liu CX.Establishment of pepsinogen reference range and its clinicalapplication in Shanghai area[J].J Mod Lab Med,2015,30(1):121-123,125.
[6] Lukaszewicz-Zaj Ac M,Mroczko B,Gryko M,et al.Comparison between clinical significance of serum proinflammatory proteins(IL-6 and CRP)and classic tumor markers(CEA and CA 19-9)in gastric cancer[J].Clinical & Experimental Medicine,2011,11(2):89-96.
[7] 廉 伟,赵 缜,赵 芳,等.三种方法检测胃蛋白酶原I的比较及临床应用[J].现代检验医学杂志,2014,29(1):132-135.
Lian W,Zhao Z,Zhao F,et al.Detection of pepsinogen I by three different methods and its clinical application[J].J Mod Lab Med,2014,29(1):132-135.
[8] Correa P.Serum pepsinogens in gastric cancer screening[J].Dig Dis Sci,2010,55(8):2123-2125.
相似文献/References:
[1]段秀枝,金苑卿.健康人群血清PG定量检测和Hp感染的临床意义[J].现代检验医学杂志,2016,31(02):26.[doi:10.3969/j.issn.1671-7414.2016.02.008]
DUAN Xiu-zhi,JIN Yuan-qing.Clinical Meaning of Pepsinogen Test and Helicobacter
Pylori Serology in the Health Check-up Population[J].Journal of Modern Laboratory Medicine,2016,31(05):26.[doi:10.3969/j.issn.1671-7414.2016.02.008]
[2]房国忠,吴 红,杨 琛.联合检测血清胃蛋白酶原和胸苷激酶1在胃部疾病诊断中的意义[J].现代检验医学杂志,2016,31(02):124.[doi:10.3969/j.issn.1671-7414.2016.02.037]
FANG Guo-zhong,WU Hong,YANG Chen.Clinical Significance of Detecting Serum Pepsinogen
and Thymidine Kinase 1 Levels in Patients with Gastric Diseases[J].Journal of Modern Laboratory Medicine,2016,31(05):124.[doi:10.3969/j.issn.1671-7414.2016.02.037]
[3]杨建华,王炳华,林 勇.血清胃蛋白酶原和胃泌素-17
对萎缩性胃炎及胃癌患者诊断价值[J].现代检验医学杂志,2016,31(03):51.[doi:10.3969/j.issn.1671-7414.2016.03.014]
YANG Jian-hua,WANG Bing-hua,LIN Yong.Clinical Value of Serum Pepsinogen and Gastrin-17 Levels
in Patients with Atrophic Gastritis and Gastric Cancer[J].Journal of Modern Laboratory Medicine,2016,31(05):51.[doi:10.3969/j.issn.1671-7414.2016.03.014]
[4]胡 娟,徐 鹏,呼永河,等.不同海拔高度人群胃蛋白酶原血清水平差异性分析[J].现代检验医学杂志,2015,30(03):32.[doi:10.3969/j.issn.1671-7414.2015.03.009]
HU Juan,XU Peng,HU Yong-he,et al.Analysis on Variations of Serum
Pepsinogen in Different Altitude Population[J].Journal of Modern Laboratory Medicine,2015,30(05):32.[doi:10.3969/j.issn.1671-7414.2015.03.009]
[5]周 勃.天津铁路健康体检员工血清胃蛋白酶原水平调查研究[J].现代检验医学杂志,2020,35(03):138.[doi:10.3969/j.issn.1671-7414.2020.03.037]
ZHOU Bo.Investigation and Study on Serum Pepsinogen Levels in Physical
Examination Staff of Tianjin Railway[J].Journal of Modern Laboratory Medicine,2020,35(05):138.[doi:10.3969/j.issn.1671-7414.2020.03.037]